Enzyme delivery systems and methods of preparation and use
First Claim
Patent Images
1. A method of treating a subject with an autism spectrum disorder, comprising administering to the subject a pharmaceutical composition comprising a coated free-flowing particulate digestive enzyme preparation, comprising particles that comprise:
- (a) a core containing digestive enzymes, wherein the digestive enzymes comprise a protease, an amylase and a lipase; and
(b) a coating comprising an emulsifiable lipid, wherein the coating coats the core and the emulsifiable lipid emulsifies upon exposure to a solvent,wherein the digestive enzymes are present in the particles in an amount of from 77.5-82.5% by weight of the particles, andwherein the coating masks the taste and smell of the digestive enzymes.
2 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations. This invention further relates to methods of preparation and use of the systems, pharmaceutical compositions and preparations to treat persons having ADD, ADHD, autism, cystic fibrosis and other behavioral and neurological disorders.
240 Citations
44 Claims
-
1. A method of treating a subject with an autism spectrum disorder, comprising administering to the subject a pharmaceutical composition comprising a coated free-flowing particulate digestive enzyme preparation, comprising particles that comprise:
-
(a) a core containing digestive enzymes, wherein the digestive enzymes comprise a protease, an amylase and a lipase; and (b) a coating comprising an emulsifiable lipid, wherein the coating coats the core and the emulsifiable lipid emulsifies upon exposure to a solvent, wherein the digestive enzymes are present in the particles in an amount of from 77.5-82.5% by weight of the particles, and wherein the coating masks the taste and smell of the digestive enzymes. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
-
30. A method of treating a subject with an autism spectrum disorder, comprising administering to the subject a pharmaceutical composition comprising a dose of a coated free-flowing particulate digestive enzyme preparation, comprising particles that comprise:
-
a core comprising digestive enzymes, wherein the digestive enzymes comprise a protease, an amylase and a lipase; and a coating to provide for controlled release of the digestive enzymes, wherein the coating comprises an emulsifiable lipid, wherein the emulsifiable lipid is a soy lipid, wherein the digestive enzymes are present in an amount of from 77.5-82.5% by weight of the particles, wherein the coating masks the taste and smell of the digestive enzymes, and wherein the digestive enzymes have a protease activity of not less than 156 USP units/mg. - View Dependent Claims (31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)
-
Specification